PaxMedica
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
303 S Broadway Ste 125, Tarrytown, New Y...Phone Number
(914) 987-2876Website
www.paxmedica.comRevenue
<$5 MillionStock Symbol
PXMDIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About PaxMedica
PaxMedica is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurodevelopmental disorders, with a primary focus on Autism Spectrum Disorder (ASD). The company aims to address the unmet needs of millions of children and adults affected by these conditions. Their lead programs are designed to bring hope and improve the lives of those struggling with ASD by targeting both its causes and symptoms. PaxMedica's work seeks to create a brighter, more independent future for individuals with autism and their families.Explore more
PaxMedica Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PaxMedica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at PaxMedica
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PaxMedica had a recent Job posting/layoffs
Earning: See what the market has to say on PaxMedica recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if PaxMedica is spiking on competitors!
Product Launch: Get notified when PaxMedica launches new products
PaxMedica, which may be a good buyer, showed buying intent in Masked Content Topic
Check if PaxMedica has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once PaxMedica has new funding data
Recommended Actions
Find VP level buyers at PaxMedica
Find 2 more new buyers
Compare Similar Companies to PaxMedica
Compare insights from companies similar to PaxMedica, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2019
KW
Karen Walton-BowenClinical Operations, Biostatistical Analysis & Reporting Head
Company Profile Activity
Activity Insights
PaxMedica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PaxMedica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PaxMedica.
PaxMedica financials insights
Gather financial insights about PaxMedica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Private Equity
$3.2M
PaxMedica Tech Stack
A closer look at the technologies used by PaxMedica
See more technologies
Most Recent Scoops
Earnings
Logistics / Supply Chain
Earnings
Financial Planning, Sales
Earnings
Asset Management, Logistics / Supply Chain
Earnings
Mergers & Acquisitions, Financial Planning, Acquisitions, Mergers
Earnings
Financial Planning, Sales
PaxMedica News & Media
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (OTC:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, provided a corporate update in light of its transition off the NASDAQ stock market, emphasizing this change will not affect the company’s commitment to advancing treatments for neurological disorders.PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
LOS ANGELES, April 26, 2024 (GLOBE NEWSWIRE) -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for IV suramin from the Ministry of Health (MOH) of Malawi, a country in east Africa. The request seeks emergency access to the Company’s recently completed registration batches of PAX-101 (IV suramin) to address thePaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency access to IV suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of Africa.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding PaxMedica
Sign Up For FreeTo access detailed company insights
PaxMedica is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for neurodevelopmental disorders, with a primary focus on Autism Spectrum Disorder (ASD). The company aims to address the unmet needs of millions of children and adults affected by these conditions. Their lead programs are designed to bring hope an... Read More
